WuXi PharmaTech (Cayman), Inc. (ADR) (WX)
China-based pharmaceutical and biotechnology R&D outsourcing company which provides a integrated portfolio of laboratory and manufacturing services in the drug discovery and development process to pharmaceutical and biotechnology companies.
Recs
00100
(96.51)
Submitted: 11/16/2009 3:28:58 PM :
Start Price:
$14.97
WX Score:
-3.30
Downthumb. Chinese biotech company. (outsourcing). Negative cash flow. Opaque financials. Low debt ratio.
Recs
jmt587
(99.82)
Submitted: 9/28/2009 3:00:37 PM :
Start Price:
$12.00
WX Score:
+24.47
Chinese BioTech & Pharma Outsourcing company.
Recs
oxdeming
(47.22)
Submitted: 9/11/2009 4:38:13 AM :
Start Price:
$11.55
WX Score:
+27.80
China pharm is in the rising
Recs
iPicksEm
(< 20)
Submitted: 5/25/2009 9:41:01 PM :
Start Price:
$7.45
WX Score:
-80.84
CAPS put this in my inbox under weekly stock ideas. Well, I'm too lazy to do research so I'm going to go out on a limb and say under perform. I say under perform ONLY because I don't know the goals of this company.
*This is part of a new game I'll be playing with CAPS recommendation. For every stock selection they send, I will spend no more then ten minutes looking at it before deciding if it will over perform or under perform.
Recs
pslorenz
(97.95)
Submitted: 4/6/2009 1:00:32 PM :
Start Price:
$4.95
WX Score:
+177.06
Outsourcing is and will continue to be a hot ticket item. Outsourcing pharma R&D is an interesting concept.
Recs
Recs
Seafairer
(73.54)
Submitted: 1/22/2009 9:53:05 AM :
Start Price:
$5.74
WX Score:
+132.87
It is Chinese, so there will be plenty of market to run in. With China's lax oversight, this company can get away with alot.
Recs
Haugurafpeningum
(98.35)
Submitted: 1/15/2009 2:01:02 PM :
Start Price:
$6.13
WX Score:
+118.22
Thanks StatsGeek
Recs
TMFBreakerThiel
(93.99)
Submitted: 1/13/2009 4:35:04 PM :
Start Price:
$7.00
WX Score:
+89.20
I like the CRO business (contract research...not drug development, as some seem to think) as a secular trend, and WuXi is the lower-cost Chinese solution. Perhaps not the greatest business moat, but at this price, I'll take the risk.
Recs
ironyworks
(95.04)
Submitted: 1/1/2009 2:17:22 AM :
Start Price:
$8.00
WX Score:
+68.61
Chinese medical services
Recs
tskephart
(80.03)
Submitted: 11/26/2008 12:30:32 PM :
Start Price:
$5.97
WX Score:
+128.10
Pharmaceutical R&D is a very expensive part of the pharmaceutical market. I feel their will be a paradigm shift on how global pharmaceutical companies approach research, one of the results will be more outsourcing and collaborations.. WuXi is positioned well to take advantage of this shift.
Recs
lwc123
(85.97)
Submitted: 10/23/2008 12:39:55 PM :
Start Price:
$7.07
WX Score:
+90.98
8x trailing EBITDA. 75% earnings growth. Market leader in China. Outsourcing is a natural in down markets. The pharma customer base is steady in a down market. Good risk-reward.
Recs
deafdumbnblind
(< 20)
Submitted: 10/22/2008 7:23:07 PM :
Start Price:
$7.50
WX Score:
+80.55
excellent company, great growth....PE 6.21 get some balls and buy !
Recs
EagleTraderOne
(70.11)
Submitted: 9/10/2008 5:04:13 PM :
Start Price:
$15.77
WX Score:
-4.38
Still a way to go...down. Not a buy...yet.
Recs
Recs
j1e1k1
(97.50)
Submitted: 6/7/2008 9:57:13 AM :
Start Price:
$19.69
WX Score:
-5.36
No-brainer.
Booming industry in booming country at a great price!
Recs
DSW0607
(< 20)
Submitted: 6/4/2008 2:44:19 PM :
Start Price:
$19.38
WX Score:
-3.55
This is a 5 star company but people are giveing away. People will soon realize the high US pharm R&D cost is not reasonable providing the high quality but cheap Chienese engineers. WX did purchase a US department and it will soon intergrate well with its China part.
Recs
TMFBiologyFool
(93.23)
Submitted: 5/28/2008 7:40:44 PM :
Start Price:
$20.29
WX Score:
-6.49
Now that the stock has come back down to earth, it should do well in the coming years. Pharma is trying to cut costs and there's no better place to get high quality scientists on the cheap than China.
Recs
stockgaucho
(< 20)
Submitted: 5/27/2008 11:44:04 PM :
Start Price:
$22.23
WX Score:
-13.17
For some reason I foresee this first quarter doubled profit company performing well in the future.
Recs
deuspecuniae
(66.25)
Submitted: 5/1/2008 12:11:17 PM :
Start Price:
$17.77
WX Score:
+4.66
The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical stocks have been beaten down this past winter, and I see a reversal across the entire sector. Also, those companies already on a run will continue due to the upward momentum this summer from key reversals and upgrades throughout the sector.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 44 1 2 3 Next »